Developing point-of-care CAR T manufacturing
European Pharmaceutical Review
DECEMBER 27, 2023
2,3 Clinical implementation of CAR T-cell technology requires a reproducible T-cell manufacturing platform, which necessitates effective gene-transfer tools and T-cell culture conditions. After this incident CAR-related toxicity scales and guidelines were established to prevent adverse reactions.
Let's personalize your content